stars 1 stars 2 stars 3

View Oxital's top competitors like AQWEST, LLC, Agile Biologics Consulting LLC, and BioSpectrum, Inc..

VistaGen Therapeutics, Inc.
VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need. Our CNS pipeline includes three drug candidates (AV-101, PH10, and PH94B) with potential for at-home use, rapid-onset therapeutic benefits and exceptional safety. Each CNS drug candidate in our pipeline is either currently in or has completed Phase 2 clinical development. AV-101, an oral NMDA receptor glycine site antagonist (a full antagonist), is in Phase 2 development in the U.S. for major depressive disorder (MDD) and in a first-step target engagement study in healthy volunteer U.S. military Veterans for suicidal ideation. The FDA has granted Fast Track designation for development of AV-101, both as a potential adjunctive treatment for MDD and as a non-opioid treatment for neuropathic pain. PH10 is a potential first-in-class neuroactive nasal spray with rapid-onset antidepressant effects observed at microgram doses and without systemic exposure. PH10 is in Phase 2 development for MDD. PH94B is a potential first-in-class neuroactive nasal spray with rapid-onset effects observed at microgram doses and without systemic exposure. Phase 2 and pilot Phase 3 development of PH94B for Social Anxiety Disorder (SAD) has been completed successfully, and PH94B is now being prepared for pivotal Phase 3 development as an on-demand PRN treatment for SAD. VistaStem Therapeutics is VistaGen's wholly owned subsidiary focused on applying human pluripotent stem cell technology, internally and with collaborators, to discover, rescue, develop and commercialize proprietary new chemical entities (NCEs), including small molecule NCEs with regenerative potential, for CNS and other diseases, and cellular therapies involving stem cell-derived blood, cartilage, heart and liver cells.
South San Francisco, California, US
Public
$1M Revenue
http://www.vistagen.com
8 Employees
VTGN Ticker
Flexitech
Are you having issues with your current hose supplier or your current hose routing? You can send a vehicle to our conveniently located Detroit, Michigan office, or to our office near Lyon, France where one of our experienced application engineers will develop a hose routing solution that will solve your problems. You can trust our 100+ years of accumulated hose routing experience. You will be impressed at how your new hose routing will look and feel and how competitively it will be priced. Regardless of how stringent your hose specification we have a hose available today that will meet it. You will also be pleased at our extensive global production footprint which allows you to receive your hose assembly from a facility near you. Please e-mail or call us today so that we can develop a routing together which will be a winning proposition for you and your customers. We welcome the opportunity to help with your supplier consolidation efforts and will work within our extensive global network to provide you with the best-in-class level of service, quality and price.
Lyon, FR
Private
$72.6M Revenue
http://www.flexitech.com
488 Employees
Madison, Wisconsin, US
Public
https://cellulardynamics.com
8 Employees
NASDAQ:ICEL Ticker
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users